FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

385287007: Parenteral dose form (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3620889014 Parenteral dose form (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620890017 Parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

78 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Parenteral dose form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Parenteral dose form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier
Parenteral dose form Is a Pharmaceutical dose form true Inferred relationship Existential restriction modifier
Parenteral dose form Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Glucose 4% / Sodium chloride 0.18% solution for injection 1litre bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 1g powder and solvent for solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 500mg powder and solvent for solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Lidocaine 44mg/2.2ml (2%) / Adrenaline 27.5micrograms/2.2ml (1 in 80,000) solution for injection cartridges Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate powder Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 125mg powder and solvent for solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 2g powder and solvent for solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Methylprednisolone sodium succinate 40mg powder and solvent for solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 20mg/4ml / Glucose 320mg/4ml solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Laryng-O-Jet 4% oromucosal solution 4ml vials (Celltech Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 25mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 50mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.45% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 1litre bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 10% / Sodium chloride 0.18% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% solution for injection 500ml polyethylene bottles Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 2.5% / Sodium chloride 0.45% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 2.5% / Sodium chloride 0.45% solution for injection 500ml polyethylene bottles Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.2% (potassium 13.3mmol/500ml) / Glucose 4% / Sodium chloride 0.18% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.2% (potassium 13.3mmol/500ml) / Sodium chloride 0.9% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.45% solution for injection 1litre bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Mepivacaine 44mg/2.2ml / Adrenaline 22micrograms/2.2ml (1 in 100,000) solution for injection cartridges Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 500mg capsules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.2% (potassium 13.3mmol/500ml) / Glucose 5% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Amphotericin (lipid formulation) Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.3% (potassium 20mmol/500ml) / Glucose 5% / Sodium chloride 0.45% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.3% (potassium 20mmol/500ml) / Glucose 10% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.6% (potassium 40mmol/500ml) / Glucose 5% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.6% (potassium 40mmol/500ml) / Sodium chloride 0.9% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.45% (potassium 60mmol/1litre) / Sodium chloride 0.9% solution for injection 1litre bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 10% solution for injection 500ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 3% (potassium 40mmol/100ml) / Sodium chloride 0.9% solution for injection 100ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 1.5% (potassium 20mmol/100ml) / Sodium chloride 0.9% solution for injection 100ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Potassium chloride 7.5% (potassium 50mmol/50ml) / Sodium chloride 0.9% solution for injection 50ml bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.9% solution for injection 1litre bags Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.25g/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.575g/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.5g/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.6g/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.75g/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1.83g/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1g/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 250mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 400mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 470mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 500mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 50mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 600mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 700mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 750mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 800mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Ferric carboxymaltose 100mg/2ml solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Ferric carboxymaltose 500mg/10ml solution for injection vials Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 1g/5ml solution for injection ampoules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 50mg capsules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 400mg capsules Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate 100mg/5ml oral solution Has manufactured dose form False Parenteral dose form Inferred relationship Existential restriction modifier
Xylocaine 1% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Xylocaine 0.5% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Cyclimorph 15 solution for injection 1ml ampoules (CeNeS Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Cyclimorph 10 solution for injection 1ml ampoules (CeNeS Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.18 glucose 4% / sodium chloride 0.18% solution for injection 1litre bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Solu-Medrone 500mg powder and solvent for solution for injection vials (Pfizer Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Solu-Medrone 1g powder and solvent for solution for injection vials (Pfizer Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Lignostab-A 2% 1 in 80,000 injection 2.2ml cartridges (Dentsply Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Xylotox 2% E80 Dental injection 2.2ml cartridges (Dentsply Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Xylocaine 2% with Adrenaline 1 in 80,000 injection 2.2ml cartridges (Dentsply Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Sodium benzoate powder (J M Loveridge Plc) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Solu-Medrone 125mg powder and solvent for solution for injection vials (Pfizer Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Solu-Medrone 2g powder and solvent for solution for injection vials (Pfizer Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Solu-Medrone 40mg powder and solvent for solution for injection vials (Pfizer Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Marcain Heavy 0.5% solution for injection 4ml ampoules (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 25mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Marcain 0.25% with Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Bupivacaine 50mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Marcain 0.5% with Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (AstraZeneca) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.45% solution for injection 500ml bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 1litre bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 500ml bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.19 glucose 10% / sodium chloride 0.18% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% solution for injection 500ml bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.18 glucose 4% / sodium chloride 0.18% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Polyfusor T glucose 4% / sodium chloride 0.18% solution for injection 500ml bottles (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 4% / Sodium chloride 0.18% solution for injection 1litre bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.3 glucose 5% / sodium chloride 0.9% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.3 glucose 5% / sodium chloride 0.9% solution for injection 1litre bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Glucose 2.5% / Sodium chloride 0.45% solution for injection 500ml bags (Baxter Healthcare Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Polyfusor TA glucose 2.5% / sodium chloride 0.45% solution for injection 500ml bottles (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Intraven glucose 4% / sodium chloride 0.18% solution for injection 1litre bags (Ivex Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Intraven glucose 4% / sodium chloride 0.18% solution for injection 500ml bags (Ivex Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Intraven glucose 5% / sodium chloride 0.9% solution for injection 1litre bags (Ivex Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Intraven glucose 5% / sodium chloride 0.9% solution for injection 500ml bags (Ivex Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Intraven glucose 5% / sodium chloride 0.45% solution for injection 500ml bags (Ivex Pharmaceuticals) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier
Steriflex No.30 potassium chloride 0.2% (potassium 13.3mmol/500ml) / glucose 4% / sodium chloride 0.18% solution for injection 500ml bags (Fresenius Kabi Ltd) Has manufactured dose form True Parenteral dose form Inferred relationship Existential restriction modifier

Start Previous Page 25 of 26 End

This concept is not in any reference sets

Back to Start